» Articles » PMID: 35749422

Motivators and Barriers Towards Clinical Research Participation: A Population-based Survey from an Arab MENA Country

Overview
Journal PLoS One
Date 2022 Jun 24
PMID 35749422
Authors
Affiliations
Soon will be listed here.
Abstract

Jordan was the first Arab country to enact clinical research regulations. The country has a well-flourished pharmaceutical industry that leans heavily on clinical research (CR) for drug development and post-marketing surveillance. In this cross-sectional study, we sought to assess the public's awareness and attitude towards CR as well as their perceived motivators and barriers to CR participation. A population-based, self-administered questionnaire was distributed to the general public in Jordan. Among the 1061 participants in this survey, 74% reported being aware of CR. The majority (70%) agreed to the role of CR in health promotion. Online information and healthcare staff were the two main sources of CR information for the participants. About 25% of the participants received prior invitations to participate in CR with 21% agreeing to participate. However, most participants of the current study (63%) were willing to participate in future CR. Contributing to science, benefiting others, and promoting one's own health were the top motivating factors for participating in CR; while time constraints, fear of research procedure, and lack of interest were the most cited reasons for rejecting participation. Filling out questionnaire surveys, donating blood samples, and participating in physical examinations were the main CR contributions of the participants. Nearly 31% of the participants believed that CR is conducted in a responsible and ethical manner, while 57% did not have an opinion regarding the same matter. In addition, 49% and 44% were neutral with regards to the degree of harm and confidentiality posed by CR. While only 27% disagreed that CR exposes participants to some form of harm, 48% either strongly agreed (15%) or agreed (33%) that it maintains high level of confidentiality for participants. The current study provides insight into the public's perception of CR in Jordan as well as its motivating factors and perceived barriers towards participating in CR. We envisage to utilize this insight as an aid in the design of vigilant future awareness campaigns and recruitment strategies.

Citing Articles

Facilitators and Barriers to Health Research Knowledge and Participation Among Arab/Middle Eastern and North African (MENA) Patients in the US.

Abouhala S, Abdulle A, Zanial N, Aziz G, Hussein A, Stiffler M J Community Health. 2024; .

PMID: 39681793 DOI: 10.1007/s10900-024-01423-9.


"Our Voices Will Get Louder": A Qualitative Exploration of Factors Influencing Arab/Middle Eastern North African (MENA) American Patient Participation in US-Based Health Care and Health Research.

Abouhala S, Abdulle A, Aziz G, Hussein A, Zanial N, Shalabi I J Racial Ethn Health Disparities. 2024; .

PMID: 39653989 DOI: 10.1007/s40615-024-02255-y.


Oncology Early-Phase Clinical Trials in the Middle East and North Africa: A Review of the Current Status, Challenges, Opportunities, and Future Directions.

Alotaibi H, Anis A, Alloghbi A, Alshammari K J Immunother Precis Oncol. 2024; 7(3):178-189.

PMID: 39219998 PMC: 11361343. DOI: 10.36401/JIPO-23-25.


The Development of a Clinical Research Model Complementing Medical Residency and the Assessment of Research Productivity.

Nair S, Al-Dahmani K Cureus. 2023; 15(11):e48684.

PMID: 38090409 PMC: 10714375. DOI: 10.7759/cureus.48684.


Attitudes Toward Providing Open Access for Use of Biospecimens and Health Records: A Cross-Sectional Study from Jordan.

Al-Shami K, Ahmed W, Alzoubi K Patient Prefer Adherence. 2023; 17:895-903.

PMID: 37013082 PMC: 10066730. DOI: 10.2147/PPA.S402769.


References
1.
Willison D, Richards D, Orth A, Harris H, Marlin S . Survey of Awareness and Perceptions of Canadians on the Benefits and Risks of Clinical Trials. Ther Innov Regul Sci. 2018; 53(5):669-677. PMC: 6710611. DOI: 10.1177/2168479018805433. View

2.
London L, Hurtado-de-Mendoza A, Song M, Nagirimadugu A, Luta G, Sheppard V . Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors. Contemp Clin Trials. 2014; 40:74-80. PMC: 4357359. DOI: 10.1016/j.cct.2014.11.013. View

3.
Quay T, Frimer L, Janssen P, Lamers Y . Barriers and facilitators to recruitment of South Asians to health research: a scoping review. BMJ Open. 2017; 7(5):e014889. PMC: 5541387. DOI: 10.1136/bmjopen-2016-014889. View

4.
Jones J, Nyhof-Young J, Moric J, Friedman A, Wells W, Catton P . Identifying motivations and barriers to patient participation in clinical trials. J Cancer Educ. 2007; 21(4):237-42. DOI: 10.1080/08858190701347838. View

5.
Khabour O, Alomari M, Al-Sheyab N . Parental Perceptions About Informed Consent/Assent in Pediatric Research in Jordan. J Empir Res Hum Res Ethics. 2017; 12(4):261-268. PMC: 5595642. DOI: 10.1177/1556264617718937. View